named programs · 1 · from sources
What they call their work
Lupus Therapy Development Program
Supports the identification and testing of promising new therapies for lupus through grants to research hospitals and academic medical centers
activities · 1 group
What they do
-
Autoimmune Disease Research Funding 1 activity
- Funding lupus therapy researchFunds research to identify and test promising new therapies for lupus, including clinical testing at institutions such as NYU Langone Medical Center and the University of Chicago.
-
financials · form 990PF · fy2023
revenue
Total revenue$1.30M
Contributions & grants$1.30M100%
Program service revenue——
Investment income$00%
Other revenue—
expenses
Total expenses$1.42M
Program expenses—
Admin / overhead—
Fundraising—
Salaries & benefits$0
Grants paid out$465K
balance sheet
Total assets$0
Cash—
Investments—
Liabilities—
Net assets$0
4 years on record · 2020–2023 · YoY revenue -49.5%
leadership · form 990 part vii · fy2023
Who runs it
board members · 5
- BEVRA H HAHN MD — TRUSTEE
- DAVID S PISETSKY MD PHD — TRUSTEE
- JOSEPH E CRAFT MD — SECRETARY AND TRUSTEE
- KATHERINE M SNIDER — PRESIDENT AND TRUSTEE
- MATTHEW H LIANG MD MPH — TRUSTEE
relationships · 3
Who they work with
- HOSPITAL FOR SPECIAL SURGERY Partner — Funded to support the identification and testing of promising new therapies for lupus.
- NYU LANGONE MEDICAL CENTER Partner — Funded for lupus testing research.
- UNIVERSITY OF CHICAGO Partner — Funded for lupus testing research.